Reaction Details |
| Report a problem with these data |
Target | POU domain, class 2, transcription factor 2 |
---|
Ligand | BDBM50576849 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | ChEMBL_2127961 (CHEMBL4837390) |
---|
IC50 | >50000±n/a nM |
---|
Citation | Kumar, S; Jaipuri, FA; Waldo, JP; Potturi, H; Marcinowicz, A; Adams, J; Van Allen, C; Zhuang, H; Vahanian, N; Link, C; Brincks, EL; Mautino, MR Discovery of indoximod prodrugs and characterization of clinical candidate NLG802. Eur J Med Chem198:0 (2020) [PubMed] Article |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
POU domain, class 2, transcription factor 2 |
---|
Name: | POU domain, class 2, transcription factor 2 |
Synonyms: | Lymphoid-restricted immunoglobulin octamer-binding protein NF-A2 | OCT2 | OCT2 | OTF-2 | OTF2 | Oct-2 | Octamer-binding protein 2 | Octamer-binding transcription factor 2 | Octamer-binding transcription factor 2 (OCT2) | PO2F2_HUMAN | POU domain, class 2, transcription factor 2 | POU2F2 |
Type: | PROTEIN |
Mol. Mass.: | 51217.88 |
Organism: | Homo sapiens (Human) |
Description: | ChEMBL_109671 |
Residue: | 479 |
Sequence: | MVHSSMGAPEIRMSKPLEAEKQGLDSPSEHTDTERNGPDTNHQNPQNKTSPFSVSPTGPS
TKIKAEDPSGDSAPAAPLPPQPAQPHLPQAQLMLTGSQLAGDIQQLLQLQQLVLVPGHHL
QPPAQFLLPQAQQSQPGLLPTPNLFQLPQQTQGALLTSQPRAGLPTQAVTRPTLPDPHLS
HPQPPKCLEPPSHPEEPSDLEELEQFARTFKQRRIKLGFTQGDVGLAMGKLYGNDFSQTT
ISRFEALNLSFKNMCKLKPLLEKWLNDAETMSVDSSLPSPNQLSSPSLGFDGLPGRRRKK
RTSIETNVRFALEKSFLANQKPTSEEILLIAEQLHMEKEVIRVWFCNRRQKEKRINPCSA
APMLPSPGKPASYSPHMVTPQGGAGTLPLSQASSSLSTTVTTLSSAVGTLHPSRTAGGGG
GGGGAAPPLNSIPSVTPPPPATTNSTNPSPQGSHSAIGLSGLNPSTGPGLWWNPAPYQP
|
|
|
BDBM50576849 |
---|
n/a |
---|
Name | BDBM50576849 |
Synonyms: | CHEMBL4876008 |
Type | Small organic molecule |
Emp. Form. | C20H30ClN3O3 |
Mol. Mass. | 395.924 |
SMILES | Cl.CCOC(=O)[C@@H](Cc1cn(C)c2ccccc12)NC(=O)[C@@H](N)CC(C)C |r| |
Structure |
|